Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's health initiative randomized trial

Anne McTiernan*, Christopher F. Martin, Jennifer D. Peck, Aaron K. Aragaki, Rowan T. Chlebowski, Etta D. Pisano, C. Y. Wang, Robert L. Brunner, Karen C. Johnson, Jo Ann E. Manson, Cora E. Lewis, Jane Morley Kotchen, Barbara S. Hulka, Barbara Alving, Jacques Rossouw, Linda Pottern, Ross Prentice, Garnet Anderson, Andrea LaCroix, Ruth E. PattersonSally Shumaker, Pentti Rautaharju, Evan Stein, Steven Cummings, John Himes, Bruce Psaty, Sylvia Wassertheil-Smoller, Jennifer Hays, Annlouise R. Assaf, Lawrence Phillips, Shirley Beresford, Judith Hsia, Cheryl Ritenbaugh, Bette Caan, Barbara V. Howard, Linda Van Horn, Henry Black, Marcia L. Stefanick, Dorothy Lane, Rebecca Jackson, Cora Beth Lewis, Tamsen Bassford, Jean Wactawski-Wende, John Robbins, Allan Hubbell, Howard Judd, Robert D. Langer, Margery Gass, Marian Limacher, David Curb, Robert Wallace, Judith Ockene, Norman Lasse, Mary Jo O'Sullivan, Karen Margolis, Robert Brunner, Gerardo Heiss, Lewis Kuller, Karen C. Johnson, Robert Brzyski, Gloria Sarto, Denise Bonds

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

190 Scopus citations

Fingerprint Dive into the research topics of 'Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's health initiative randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences